Sign up to save your podcasts
Or
Share Teva CEO Richard Francis Talks Tariffs, Generic Drugs Market
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Teva CEO Richard Francis Talks Tariffs, Generic Drugs Market
Teva Pharmaceutical Industries reported its second-quarter 2025 financial results on Wednesday, reflecting a mixed performance amid continued shifts in its portfolio strategy. CEO Richard Francis speaks with Bloomberg's Scarlet Fu and Katie Griefeld.
See omnystudio.com/listener for privacy information.
View all episodes
By Bloomberg
4.6
1616 ratings
Teva Pharmaceutical Industries reported its second-quarter 2025 financial results on Wednesday, reflecting a mixed performance amid continued shifts in its portfolio strategy. CEO Richard Francis speaks with Bloomberg's Scarlet Fu and Katie Griefeld.
See omnystudio.com/listener for privacy information.
More shows like Bloomberg Talks
View all
Exchanges
970 Listeners
Bloomberg Intelligence
404 Listeners
Bloomberg Surveillance
1,170 Listeners
Masters in Business
2,201 Listeners
Odd Lots
1,967 Listeners
Bloomberg Businessweek
420 Listeners
Foundering
969 Listeners
Capital Allocators – Inside the Institutional Investment Industry
797 Listeners
Trillions
198 Listeners
Making Sense
72 Listeners
Value Investing with Legends
210 Listeners
Thoughts on the Market
1,302 Listeners
Here's Why
62 Listeners
Out of Office
30 Listeners
Wall Street Week
59 Listeners
The Memo by Howard Marks
418 Listeners
Listen to the Story
5 Listeners
Into the Metaverse
58 Listeners
Bedrock, USA
233 Listeners
Zero: The Climate Race
234 Listeners
Bloomberg Tech
63 Listeners
Bloomberg Daybreak: US Edition
85 Listeners
The Markets
80 Listeners
Bloomberg News Now
76 Listeners
The Deal with Alex Rodriguez and Jason Kelly
86 Listeners
Money Stuff: The Podcast
403 Listeners
Leaders with Francine Lacqua
12 Listeners
Bloomberg Opinion
7 Listeners
The Cable
2 Listeners
The Sixth Bureau
114 Listeners